Navigation

    Forum

    • Register
    • Login
    • Search
    • Categories
    • Recent
    • Popular
    • Users
    • Groups

    Efficacy Data

    PAAB Code
    2
    2
    88
    Loading More Posts
    • Oldest to Newest
    • Newest to Oldest
    • Most Votes
    Reply
    • Reply as topic
    Log in to reply
    This topic has been deleted. Only users with topic management privileges can see it.
    • G
      GMC last edited by

      Can we present non-significant (N/S) efficacy data in an APS that is included in the Product Monograph (Part II: Clinical trials section)? Does it matter if it’s a primary, secondary or exploratory endpoint? If we can present N/S efficacy data, what parameters are required in order to present these in an APS?

      Jennifer Carroll 1 Reply Last reply Reply Quote 0
      • Jennifer Carroll
        Jennifer Carroll @GMC last edited by

        Good morning @gmc

        Similar to Q&A 332, p=ns data from the PM clinical trials section may be included in advertising providing there are no conclusions or claims that extend beyond that found in the PM. This is possible regardless of whether it is primary, secondary or exploratory.

        1 Reply Last reply Reply Quote 0
        • First post
          Last post